Memphasys (MEM) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock MEM Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Memphasys Limited Initiates Trading Halt for Capital Raising Announcement3 hours ago | tipranks.comMemphasys Expands EU Presence with ITL Contract Upgrade5 hours ago | tipranks.comMemphasys Limited Announces Board Changes with Departure of Non-Executive DirectorJuly 25, 2025 | tipranks.comMemphasys Limited Announces Venue Change for General MeetingJuly 24, 2025 | tipranks.comMemphasys Appoints Marjan Mikel as Non-Executive Director to Boost Global ExpansionJune 19, 2025 | tipranks.comMemphasys Limited Appoints New Auditor Amidst Strategic Commercialization EffortsMay 25, 2025 | tipranks.comMemphasys Secures Funding to Boost Reproductive Biotech InnovationsApril 13, 2025 | tipranks.comMemphasys Expands RoXsta™ Applications in Livestock SectorApril 2, 2025 | tipranks.comMemphasys Initiates Trading Halt Ahead of Felix™ System Trial ResultsMarch 19, 2025 | tipranks.comMemphasys Secures Loan to Advance Felix System CommercializationMarch 12, 2025 | tipranks.comMemphasys Completes Data Lock for Felix™ Clinical Trial, Eyes CE Mark ApprovalFebruary 23, 2025 | tipranks.comMemphasys Unveils Diagnostic Breakthrough with RoXsta™ SystemJanuary 15, 2025 | tipranks.comMemphasys Reaches AU$20m Market Cap Benefiting Insider Stock BuyingMay 21, 2023 | hk.finance.yahoo.comMemphasys Reaches AU$20m Market Cap Benefiting Insider Stock Buying \May 20, 2023 | finance.yahoo.comBlood pressure rises at Aegros, the next plasma hopefulApril 5, 2023 | afr.comDr Boreham’s Crucible: Every sperm is sacred – and profitableApril 2, 2023 | msn.comMemphasys Limited (IG7.F)March 9, 2023 | finance.yahoo.comMemphasys First Half 2023 Earnings: AU$0.001 loss per share (vs AU$0.001 loss in 1H 2022)February 25, 2023 | finance.yahoo.comResearch Insight View on Centrifugation-free Sperm Separation Systems Market Size [2023-2028] | Emerging Trend and Current DevelopmentsFebruary 23, 2023 | marketwatch.comASX Health Stocks: Creso eyes psychedelic spinout off the back of landmark TGA decisionFebruary 6, 2023 | msn.comA Memphasys Limited (ASX:MEM) insider increased their holdings by 6.2% last yearDecember 11, 2022 | finance.yahoo.comPlacement outbreak: Creso Pharma, New World, Memphasys chase investorsJuly 27, 2022 | afr.comASX Health Stocks: Neurotech says its cannabis strain works well when combined with DiclofenacJune 9, 2022 | msn.comMemphasys achieves quality certification for medical devices and diagnosticsMarch 20, 2022 | proactiveinvestors.com.auMemphasys outlines vision for biological separation tech in 2022January 26, 2022 | proactiveinvestors.com.auStandouts: 3 ASX biotech shares that outperformed in NovemberDecember 8, 2021 | msn.comMemphasys Limited (MEM.AX)December 7, 2021 | au.finance.yahoo.comThese 3 ASX healthcare shares are soaring today. Why?November 16, 2021 | msn.comASX Health Stocks: Paradigm rockets 21pc after getting FDA nod, Memphasys up 31pc on imminent launchNovember 2, 2021 | msn.comEllume is making news and these ASX shares are surging, againJuly 29, 2021 | fool.com.auWhen Ellume is making news, these ASX shares are in focusJuly 27, 2021 | msn.com Get Memphasys News Delivered to You Automatically Sign up to receive the latest news and ratings for MEM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MEM Media Mentions By Week MEM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MEM News Sentiment▼0.000.92▲Average Medical News Sentiment MEM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MEM Articles This Week▼20▲MEM Articles Average Week Get the Latest News and Ratings for MEM and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Memphasys and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies HEMO News SBTX News MBX News SAR News AREC News FUM News GSD News HEM News IBIO News FAB News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:MEM) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Memphasys Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Memphasys With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MEM Stock Alerts